The Impacts of Covid-19 on Individuals with Cardiovascular Disease
Jaqueline Luche Neves* and Luciane Cristine Ribeiro Rodrigues
Department of Medicine and Health, Fundação Educacional do Município de Assis (FEMA), Brazil
*Corresponding Author: Jaqueline Luche Neves, Department of Medicine and Health, Fundação Educacional do Município de Assis (FEMA), Brazil.
July 07, 2023; Published: August 23, 2023
In the face of the COVID19 pandemic, people with prior cardiovascular disease (CVD) were more likely to develop worrisome forms of the disease. With this scenario comes the importance of a watchful and expanded look at CVD patients who have had COVID19. This study aimed to identify the consequences of COVID19 in these patients. This is a cross-sectional, mixed, analytical study, with the application of a questionnaire to patients with CVD. It was concluded that at the time of COVID19 infection, 80% of respondents were already vaccinated, resulting in mild symptomatic conditions and low hospitalization rates. The length of hospital stay in individuals without vaccination of any dose of the vaccine had a significantly higher average, 16.5±2.1 days, when compared to those who were already vaccinated, 3.5±0.7 days. There were no hospitalizations in vaccinated patients with more than 2 doses. After infection, 56% of the participants began to experience dyspnea on mild-moderate exertion, 63% experienced episodes of tachycardia and blood pressure lability, among other symptoms: weaknesses, memory and psychic alterations. We conclude the need for long-term follow-up of these patients, due to the high rates of development of sequelae presented. In addition, it observed a beneficial effect of vaccination.
Keywords: Cardiovascular Disease; COVID19; Coronavirus
- Paz RC., et al. “Suggestion of a clinical protocol for elderly patients with heart disease assisted by the Brazilian Unified Health System”. Scient. Sena Aires 7.2 (2018): 88-94.
- Birth PV., et al. “Main fatal outcomes in individuals with heart disease affected by Covid-19”. Focus 11 (2020): 46-51.
- Ministry of Health. Report of the Mortality Information System- SIM. Brasilia/DF (2019).
- Ministry of Health. “Temporal trends in risk and protective behaviors related to chronic diseases among adults: differences by sex, 2006-2019”. Epidemiological Bulletin. Brasilia/DF7 (2021).
- Cavalcante JS., et al. “Chronic non-communicable diseases and factors associated with the symptoms of cardiovascular diseases”. Interdisciplinary Exhibition of the Nursing Course- Catholic University Center of Quixadá (2019): 2448-1203.
- Siqueira ASE., et al. “ Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil”. Arquivos Brasileiros de Cardiologia 1 (2017): 39-46.
- Tarasoutchi F., et al. “Update of the Brazilian Guidelines on Valvular Diseases: Approach to Anatomically Important Lesions”. Arquivos Brasileiros de Cardiologia 6 (2017): 1-34.
- Precoma DB., et al. “Update of the Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019”. Arquivos Brasileiros de Cardiologia 4 (2019): 787-891.
- Massa KHC., et al. “Analysis of the prevalence of cardiovascular diseases and associated factors in the elderly, 2000-2010”. Science and Collective Health1 (2019): 105-114.
- da Silva Freire AK., et al. “Panorama in Brazil of cardiovascular diseases of the last fourteen years from the perspective of health promotion”. Health 9 (2018).
- Santos LST de A., et al. “Barriers to cardiac rehabilitation in a city in northeastern Brazil”. Acta Fisiátr2 (2017): 67-71.
- Carvalho T., et al. “Brazilian Cardiovascular Rehabilitation Guideline - 2020”. Arquivos Brasileiros de Cardiologia 5 (2020): 943-987.
- Mehra MR., et al. “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19”. The New England Journal of Medicine 25 (2020).
- Prado PR., et al. “Risk factors for death from COVID-19 in Acre, 2020: retrospective cohort”. Epidemiology and Health Services3 (2021).
- Xavier AR., et al. “COVID-19: clinical and laboratory manifestations in infection by the novel coronavirus”. Jornal Brasileiro de Patologia e Medicina Laboratorial 56 (2020): 1-9.
- Askin L, ., et al. “The Effect of Coronavirus Disease 2019 on Cardiovascular Disease”. Arquivos Brasileiros de Cardiologia 5 (2020): 817-822.
- Colombo CSSS., et al. “Positioning on Cardiac Pre-Participation Assessment after Covid-19: Guidelines for Returning to Physical Exercise and Sports-2020”. Arquivos Brasileiros de Cardiologia 6 (2020): 1213-1226.
- Shafi AMA., et al. “Cardiac manifestations in COVID-19 patients-A systematic review”. Journal of Cardiac Surgery 8 (2020): 1988-2008.
- Bardin L. “Content analysis, São Paulo” 70 (2011): 229.
- Miranda RAR and Ostolin TLVP. “Map of Evidence on Sequelae and Post-Covid-19 Rehabilitation: Full Report. São Paulo: BIREME/PAHO/WHO (2022).
- Bridges L., et al. “Clinical profile and factors associated with the death of COVID-19 patients in the early months of the pandemic”. Escola Anna Nery (2020): 26.
- Pitanga FJG., et al. “Physical inactivity, obesity, and COVID-19: perspectives among multiple pandemics”. Bras. Act. Fis. Health 25 (2020): 1-4.
- Martins WA., et al. “Vaccination of the Cardiac Patient against COVID-19: The Reasons for Priority”. Arquivos Brasileiros de Cardiologia 2 (2021): 213-218.
- Nadanovsky P. “How to interpret the benefits of vaccines against Covid-19? ENSP REPORT”. Fio Cruz (2021).
- Orellana JDY., et al. “Changes in the pattern of hospitalizations and deaths from COVID-19 after substantial vaccination of the elderly in Manaus, Amazonas, Brazil”. Cardiac Public Health5 (2022).
- FABIÁN GM., et al. “Post-COVID Syndrome and Chronic Fatigue Syndrome: Two sides of the same coin?” La Prensa Médica Argentina 7 (2021).
- Del Rio R., et al. “Potential Role of Autonomic Dysfunction in Covid-19 Morbidity and Mortality”. Frontiers in Physiology 11 (2020): 561749.
- Salazar GO., et al. “Sars-Cov-2 infection and autonomic dysfunction - Blood pressure lability in Covid-19”. Rev Bras Hipertens1 (2022): 10-3
- GEROME AMM. “The perception of what people with Covid-19 have experienced”. Maceió: Federal University of Alagoas (2021).
- Stefano GB. “Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID”. Medical Science Monitor 27 (2021):
- Barberato SH., et al. “Transthoracic Echocardiogram Findings in Patients Hospitalized with COVID-19: Results from the Brazilian Registry of Echocardiography during the COVID-19 Pandemic (ECOVID)”. Arquivos Brasileiros de Cardiologia 4 (2021): eabc256.
- Pavon-Rojas A., et al. “Cardiovascular complications in patients with COVID-19”. Cuban Journal of Military Medicine 3 (2021).
- Asturian K. “The role of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with Covid-19: a narrative review”. Revista Ciencia Agronomica 30 (2021): 215035.
- Hierrezuelo-Rojas N., et al. “Pathophysiology of heart failure in patients with COVID-19”. Rev Inf Cient3 (2021).
- Vigário LC., et al. “The Role of the Immune System on the Cardiac Complications Observed in SARS-CoV-2”. International Journal of Cardiovascular Sciences 3 (2022): 410-418.
- Aguiar BF., et al. “Sequelae of Covid-19: a reflection on the impacts on workers' health”. Research, Society and Development 14 (2021).
- Yusvisaret Palmer L., et al. “Prevalence of depression during COVID-19 in medical students at a Mexican private university”. MEDISAN 3 (2021): 637-646.
- Logue JK., et al. “Sequelae in adults at 6 months after COVID-19 infection”. JAMA Network Open2 (2021): e210830.